¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Propranolol"¿¡ ´ëÇÑ ¿µ¿µ ÀÇÇлçÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
propranolol <drug> Potent adrenergic antagonist acting at beta-1 and beta-2 adrenergic receptors.
Pharmacologic action: Non-selective beta blockade (beta-1 and beta-2), reduces heart rate, myocardial contractility, and blood pressure, but also reduces myocardial oxygen demand.
Uses: Atrial and ventricular tachyarrhythmias caused by catecholamines; hypertension, myocardial ischemia; hyperthyroidism, hypertrophic cardiomyopathy.
Dose: 0.25 - 0.5 mg test dose, then 1 mg IV q min to desired effect Total dose should not exceed 0.1 mg/kg.
Onset: 2 min Duration: 1 - 6 hr.
Potential complications: Hypotension, bradycardia, worsened AV block, congestive heart failure and bronchospasm are unusual at low doses.
Chemical name: 1-(isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride.
(17 Mar 2000)
propranolol N-desisopropylase <enzyme> Liver microsomal enzyme containing cytochrome p-448
Registry number: EC 1.-
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á